Literature DB >> 8394237

Neuropsychological deficits in abstinent cocaine abusers: preliminary findings after two weeks of abstinence.

J Berry1, W G van Gorp, D S Herzberg, C Hinkin, K Boone, L Steinman, J N Wilkins.   

Abstract

Sixteen subjects hospitalized for treatment of cocaine dependence were administered a battery of neuropsychological tests within 72 h of last cocaine use and again approximately 2 weeks later. Twenty-one non-cocaine using control subjects, matched for age, gender, ethnicity and education, also received neuropsychological testing. Abstinence from mood altering substances during the 2-week study period was verified for both groups on three occasions using quantitative urine analysis. The results suggest that recent cocaine use is associated with impairment in memory, visuospatial abilities, and concentration during the acute phase of withdrawal, independent of withdrawal-related depression. Furthermore, many of these deficits appear to persist at least 2 weeks beyond cessation of cocaine use.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8394237     DOI: 10.1016/0376-8716(93)90087-7

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  35 in total

Review 1.  Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse.

Authors:  Antonio Verdejo-García; Francisca López-Torrecillas; Carmen Orozco Giménez; Miguel Pérez-García
Journal:  Neuropsychol Rev       Date:  2004-03       Impact factor: 7.444

Review 2.  Are executive function and impulsivity antipodes? A conceptual reconstruction with special reference to addiction.

Authors:  Warren K Bickel; David P Jarmolowicz; E Terry Mueller; Kirstin M Gatchalian; Samuel M McClure
Journal:  Psychopharmacology (Berl)       Date:  2012-03-24       Impact factor: 4.530

Review 3.  Neuropsychiatric effects of cocaine use disorders.

Authors:  Charles U Nnadi; Olubansile A Mimiko; Henry L McCurtis; Jean Lud Cadet
Journal:  J Natl Med Assoc       Date:  2005-11       Impact factor: 1.798

Review 4.  The role of cognitive control in cocaine dependence.

Authors:  Hugh Garavan; Robert Hester
Journal:  Neuropsychol Rev       Date:  2007-08-07       Impact factor: 7.444

Review 5.  Neuropsychological consequences of HIV and substance abuse: a literature review and implications for treatment and future research.

Authors:  Lisa R Norman; Michael Basso; Anil Kumar; Robert Malow
Journal:  Curr Drug Abuse Rev       Date:  2009-05

6.  FAS and CFL forms of verbal fluency differ in difficulty: a meta-analytic study.

Authors:  Danielle Barry; Marsha E Bates; Erich Labouvie
Journal:  Appl Neuropsychol       Date:  2008

7.  The neuropsychology of cocaine addiction: recent cocaine use masks impairment.

Authors:  Patricia A Woicik; Scott J Moeller; Nelly Alia-Klein; Thomas Maloney; Tanya M Lukasik; Olga Yeliosof; Gene-Jack Wang; Nora D Volkow; Rita Z Goldstein
Journal:  Neuropsychopharmacology       Date:  2008-05-21       Impact factor: 7.853

8.  Functional consequences of cocaine re-exposure after discontinuation of cocaine availability.

Authors:  Thomas J R Beveridge; Hilary R Smith; Susan H Nader; Michael A Nader; Linda J Porrino
Journal:  Neuropharmacology       Date:  2014-06-19       Impact factor: 5.250

9.  Crack cocaine use impairs anterior cingulate and prefrontal cortex function in women with HIV infection.

Authors:  Vanessa J Meyer; Deborah M Little; Daniel A Fitzgerald; Erin E Sundermann; Leah H Rubin; Eileen M Martin; Kathleen M Weber; Mardge H Cohen; Pauline M Maki
Journal:  J Neurovirol       Date:  2014-04-24       Impact factor: 2.643

10.  Neurocognitive impact of substance use in HIV infection.

Authors:  Desiree A Byrd; Robert P Fellows; Susan Morgello; Donald Franklin; Robert K Heaton; Reena Deutsch; J Hampton Atkinson; David B Clifford; Ann C Collier; Christina M Marra; Benjamin Gelman; J Allen McCutchan; Nichole A Duarte; David M Simpson; Justin McArthur; Igor Grant
Journal:  J Acquir Immune Defic Syndr       Date:  2011-10-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.